Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Saccharide-based contrast agents. Characteristics and diagnostic potential

R Schürmann1, R Schlief

  • 1Clinical Development Diagnostics, Schering AG, Berlin, Germany.

La Radiologia Medica
|May 1, 1994
PubMed
Summary

New ultrasound contrast agents, like Levovist, significantly improve Doppler signal intensity for enhanced vascular imaging. This advancement aids diagnosis, reducing the need for more invasive procedures and increasing diagnostic confidence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time monitoring of plasmon induced dissociative electron transfer to the potential DNA radiosensitizer 8-bromoadenine.

Nanoscale·2017
Same author

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens.

Climacteric : the journal of the International Menopause Society·2004
Same author

Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease.

Ultrasound in medicine & biology·2000
Same author

Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media.

European radiology·1999
Same author

Wideband harmonic imaging: a novel contrast ultrasound imaging technique.

European radiology·1999
Same author

Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience.

Radiology·1999

Failed At:

2026-06-19T13:49:46.005034+00:00

Related Experiment Videos